Livia Garavelli1, Ilenia Maini2, Federica Baccilieri2, Ivan Ivanovski2,3, Marzia Pollazzon2, Simonetta Rosato2, Lorenzo Iughetti4, Sheila Unger5, Andrea Superti-Furga6, Marco Tartaglia7. 1. Clinical Genetics Unit, Department of Obstetrics and Paediatrics, IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. garavelli.livia@asmn.re.it. 2. Clinical Genetics Unit, Department of Obstetrics and Paediatrics, IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. 3. Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy. 4. Department of Medical and Surgical Sciences of Childhood and Adult, University of Modena and Reggio Emilia, Modena, Italy. 5. Medical Genetics Service, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. 6. Department of Paediatrics, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. 7. Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Abstract
UNLABELLED: Myhre syndrome (OMIM 139210) is a rare developmental disorder inherited as an autosomal dominant trait and caused by a narrow spectrum of missense mutations in the SMAD4 gene. The condition features characteristic face, short stature, skeletal anomalies, muscle pseudohypertrophy, restricted joint mobility, stiff and thick skin, and variable intellectual disability. While most of the clinical features manifest during childhood, the diagnosis may be challenging during the first years of life. We report on the evolution of the clinical features of Myhre syndrome during childhood in a subject with molecularly confirmed diagnosis. The clinical records of 48 affected patients were retrospectively analysed to identify any early clinical signs characterizing this disorder and to better delineate its natural history. We also note that pericarditis and laryngotracheal involvement represent important life-threatening complications of Myhre syndrome that justify the recommendation for cardiological and ENT follow-up for these patients. CONCLUSION: Short length/stature, short palpebral fissures, and brachydactyly with hyperconvex nails represent signs/features that might lead to the correct diagnosis in the first years of life and direct to the proper molecular analysis. We underline the clinical relevance of pericarditis and laryngotracheal stenosis as life-threatening complications of this disorder and the need for careful monitoring, in relation to their severity. WHAT IS KNOWN: • The clinical and radiological signs of the disease in children older than 7-8 years. • Pericarditis, sometimes occurring with constrictive pericardium requiring pericardiectomy, has been reported as a recurrent feature but has not been adequately stressed in previous literature. What is New: • Short length/stature, short palpebral fissures, brachydactyly with hyperconvex nails represent clinical signs that might lead to diagnosis in the first years of life. • Review of the literature showed that pericarditis and laryngotracheal complications represent major recurrent issues in patients with Myhre syndrome.
UNLABELLED: Myhre syndrome (OMIM 139210) is a rare developmental disorder inherited as an autosomal dominant trait and caused by a narrow spectrum of missense mutations in the SMAD4 gene. The condition features characteristic face, short stature, skeletal anomalies, muscle pseudohypertrophy, restricted joint mobility, stiff and thick skin, and variable intellectual disability. While most of the clinical features manifest during childhood, the diagnosis may be challenging during the first years of life. We report on the evolution of the clinical features of Myhre syndrome during childhood in a subject with molecularly confirmed diagnosis. The clinical records of 48 affected patients were retrospectively analysed to identify any early clinical signs characterizing this disorder and to better delineate its natural history. We also note that pericarditis and laryngotracheal involvement represent important life-threatening complications of Myhre syndrome that justify the recommendation for cardiological and ENT follow-up for these patients. CONCLUSION: Short length/stature, short palpebral fissures, and brachydactyly with hyperconvex nails represent signs/features that might lead to the correct diagnosis in the first years of life and direct to the proper molecular analysis. We underline the clinical relevance of pericarditis and laryngotracheal stenosis as life-threatening complications of this disorder and the need for careful monitoring, in relation to their severity. WHAT IS KNOWN: • The clinical and radiological signs of the disease in children older than 7-8 years. • Pericarditis, sometimes occurring with constrictive pericardium requiring pericardiectomy, has been reported as a recurrent feature but has not been adequately stressed in previous literature. What is New: • Short length/stature, short palpebral fissures, brachydactyly with hyperconvex nails represent clinical signs that might lead to diagnosis in the first years of life. • Review of the literature showed that pericarditis and laryngotracheal complications represent major recurrent issues in patients with Myhre syndrome.
Authors: M G Lopez-Cardona; D Garcia-Cruz; J E Garcia-Ortiz; N O Davalos; A Feria-Velasco; L X Rodriguez-Rojas; M O Garcia-Cruz; L E Figuera-Villanueva; A Stephens; F Larios-Arceo; J Sanchez-Corona Journal: Clin Dysmorphol Date: 2004-04 Impact factor: 0.816
Authors: Lois J Starr; Dorothy K Grange; Jeffrey W Delaney; Anji T Yetman; James M Hammel; Jennifer N Sanmann; Deborah A Perry; G Bradley Schaefer; Ann Haskins Olney Journal: Am J Med Genet A Date: 2015-09-30 Impact factor: 2.802
Authors: Christoph Kenis; Margriet Verstreken; Katrien Gieraerts; Bert De Foer; Nathalie Van der Aa; Erwin F Offeciers; Jan W Casselman Journal: Otol Neurotol Date: 2014-10 Impact factor: 2.311
Authors: Viviana Caputo; Gianfranco Bocchinfuso; Marco Castori; Alice Traversa; Antonio Pizzuti; Lorenzo Stella; Paola Grammatico; Marco Tartaglia Journal: Am J Med Genet A Date: 2014-04-08 Impact factor: 2.802
Authors: Caroline Michot; Carine Le Goff; Clémentine Mahaut; Alexandra Afenjar; Alice S Brooks; Philippe M Campeau; Anne Destree; Maja Di Rocco; Dian Donnai; Raoul Hennekam; Delphine Heron; Sébastien Jacquemont; Peter Kannu; Angela E Lin; Sylvie Manouvrier-Hanu; Sahar Mansour; Sandrine Marlin; Ruth McGowan; Helen Murphy; Annick Raas-Rothschild; Marlène Rio; Marleen Simon; Irene Stolte-Dijkstra; James R Stone; Yves Sznajer; John Tolmie; Renaud Touraine; Jenneke van den Ende; Nathalie Van der Aa; Ton van Essen; Alain Verloes; Arnold Munnich; Valérie Cormier-Daire Journal: Eur J Hum Genet Date: 2014-01-15 Impact factor: 4.246
Authors: Min Jin Jeon; Min Jung Kim; Ji Hye Kim; Ji Soo Park; Jisook Yim; Myungshin Kim; Seong Keun Kwon; Soyoung Lee; Jung Min Ko; Jong-Hee Chae; Dong In Suh Journal: Pediatr Allergy Immunol Pulmonol Date: 2021-06 Impact factor: 0.885